TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $119,033 | – | 24,243 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | 24,411,968 | $119,862,763 | 3.09% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,466,977 | $12,112,857 | 0.47% |
| PenderFund Capital Management Ltd. | 145,000 | $964,372 | 0.26% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 233,600 | $1,146,976 | 0.20% |
| Black Maple Capital Management LP | 63,923 | $313,862 | 0.19% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 959,567 | $4,711,474 | 0.17% |
| Carmignac Gestion | 513,852 | $2,523,013 | 0.04% |
| WATER ISLAND CAPITAL LLC | 48,157 | $236 | 0.03% |
| CSS LLC/IL | 75,272 | $369,586 | 0.02% |
| Skandinaviska Enskilda Banken AB (publ) | 395,971 | $1,944,218 | 0.01% |